Suppr超能文献

标准化石榴(Pomella)和红枫(Maplifa)提取物及其酚类物质通过抑制基质金属蛋白酶、胶原酶和胶原交联来保护 I 型胶原蛋白。

Standardized Pomegranate (Pomella) and Red Maple (Maplifa) Extracts and Their Phenolics Protect Type I Collagen by the Inhibition of Matrix Metalloproteinases, Collagenase, and Collagen Cross-Linking.

机构信息

School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.

International Healthcare Innovation Institute (Jiangmen), Jiangmen 529020, China.

出版信息

Molecules. 2022 Nov 16;27(22):7919. doi: 10.3390/molecules27227919.

Abstract

Phenolics enriched pomegranate fruit (Pomella) and red maple leaf (Maplifa) extracts and their major phenolic constituents have demonstrated beneficial skin effects through the protection of human skin keratinocytes from oxidative-stress-induced damage. However, their mechanisms of protection of cutaneous collagen are still unclear. Herein, the collagen protective effects of Pomella and Maplifa, and their major bioactive phytochemicals, namely, punicalagin (PA) and ginnalin A (GA), respectively, were evaluated using enzymatic assays including collagenase, anti-glycation and cell-based models as well as computational methods. The importance of the modulatory effects was validated at the protein level for type I collagen and matrix metalloproteinases (MMPs) using human-skin-derived keratinocytes. The synergistic collagenase inhibitory effects upon combinations of Pomella + Maplifa and PA + GA at a combination ratio of 1:2 and 1:1, respectively, were evaluated using their combination index (CI; a well-established assessment of synergism). Pomella (50-400 µg/mL), Maplifa (100-800 µg/mL), PA (50-400 µM), and GA (50-400 µM) dose-dependently inhibited collagenase activity by 26.3-86.3%, 25.7-94.0%, 26.2-94.0%, and 12.0-98.0%, respectively. The CI of the anti-collagenase activity of Pomella and Maplifa ranged from 0.53-0.90, while that of PA and GA (12.5/12.5 and 25/25 µM) ranged from 0.66 and 0.69, respectively, suggesting a synergistic inhibitory effect. Interestingly, in the cell-based assays by Western blotting, Pomella and Maplifa reduced the protein expression levels of collagen degradation enzymes (MMPs), while simultaneously increasing that of type I collagen in epidermoid carcinoma A431 cells. This is the first report to show that these extracts exert synergistic collagen protective effects. Taken together, these findings provide molecular insights into the usefulness of Pomella and Maplifa or their phenolics as bioactive ingredients for skin care products to slow down aging and enhance skin tone.

摘要

富含多酚的石榴果实(Pomella)和红枫树叶(Maplifa)提取物及其主要酚类成分已被证明通过保护人皮肤角质形成细胞免受氧化应激诱导的损伤,对皮肤具有有益的作用。然而,其保护皮肤胶原的机制尚不清楚。在此,通过酶促测定(包括胶原酶、抗糖化和细胞模型)以及计算方法,评估了 Pomella 和 Maplifa 及其主要生物活性植物化学物质,即 punicalagin(PA)和 ginnalin A(GA)对皮肤胶原的保护作用。使用人源性皮肤角质形成细胞,在蛋白质水平上验证了对 I 型胶原和基质金属蛋白酶(MMPs)的调节作用。评估了 Pomella + Maplifa 和 PA + GA 以 1:2 和 1:1 的组合比例组合时的胶原酶抑制协同作用的重要性,使用它们的组合指数(CI;一种评估协同作用的既定方法)。Pomella(50-400μg/mL)、Maplifa(100-800μg/mL)、PA(50-400μM)和 GA(50-400μM)剂量依赖性地抑制胶原酶活性分别为 26.3-86.3%、25.7-94.0%、26.2-94.0%和 12.0-98.0%。Pomella 和 Maplifa 的抗胶原酶活性的 CI 范围为 0.53-0.90,而 PA 和 GA(12.5/12.5 和 25/25μM)的 CI 范围分别为 0.66 和 0.69,表明具有协同抑制作用。有趣的是,在基于细胞的测定中通过 Western blot,Pomella 和 Maplifa 降低了角质形成癌细胞 A431 中胶原降解酶(MMPs)的蛋白表达水平,同时增加了 I 型胶原的蛋白表达水平。这是首次报道这些提取物具有协同的胶原保护作用。总的来说,这些发现为 Pomella 和 Maplifa 或其酚类作为护肤品中的生物活性成分用于减缓衰老和增强肤色提供了分子见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acb1/9696304/0ebb441b76a5/molecules-27-07919-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验